Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.


May 17

Weekly Gain

SolarCity (NASDAQ: SCTY  )



E-Commerce China Dangdang (NYSE: DANG  )



Infinera (NASDAQ: INFN  )



MannKind (NASDAQ: MNKD  )



ACADIA Pharmaceuticals (NASDAQ: ACAD  )



Source: Barron's.

Let's start with SolarCity. This company is an installer of solar energy panels with a unique pricing model, allowing buyers to pay in monthly installments comparable to the rates that they'd save in electricity. It seems as if everything Elon Musk touches turns into sun-drenched gold, and SolarCity is no exception. Shares rose like the morning sun after the company lined up a $500 million financing package that will help it expand aggressively.

Dangdang moved higher on upbeat quarterly results. Revenue climbed 23% for the fast-growing Chinese e-tailer, and Dangdang's net deficit of $0.15 a share was considerably less than what analysts were expecting.

Infinera rose after the company presented at J.P. Morgan Global Technology, Media, and Telecom Conference. No, speaking at an analyst powwow isn't always a ticket to big gains. After all, there were other presenters there that weren't treated to robust moves higher. However, Infinera was able to explain its technology and show off its latest digital optical networking systems. After trading in the single digits since January of last year, the stock finally broke into the double digits.

MannKind moved higher after analysts at MLV & Co. initiated coverage with a "buy" rating. The market's been buzzing lately about the potential for MannKind's Afrezza, an inhalable insulin that, if it gains regulatory approval, would come as a welcome relief to diabetes sufferers who are tired of needle pricks.

ACADIA Pharmaceuticals moved higher after Roth Capital Partners analyst Robert Hazlett suggested that the biotech is an attractive buyout candidate. The shares remained robust even after the company priced a secondary offering in a move that's dilutive to existing stakeholders and would make a potential acquisition more expensive.

Keep the good vibes coming
Profiting from our increasingly global economy can be as easy as investing in your own backyard. The Motley Fool's free report "3 American Companies Set to Dominate the World" shows you how. Click here to get your free copy before it's gone.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2439711, ~/Articles/ArticleHandler.aspx, 10/1/2016 1:27:36 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 4 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 4:00 PM
ACAD $31.81 Down -0.89 -2.72%
ACADIA Pharmaceuti… CAPS Rating: **
DANG $0.00 Down +0.00 +0.00%
E-Commerce China D… CAPS Rating: **
INFN $9.03 Up +0.16 +1.80%
Infinera CAPS Rating: *****
MNKD $0.62 Up +0.02 +3.63%
MannKind CAPS Rating: *